Oral estrogen leads to falsely low concentrations of estradiol in a common immunoassay.

Lauren R CirrincioneBridgit O CrewsJane A DickersonMatthew D KrasowskiJessica RongitschKatherine L ImborekZil GoldsteinDina N Greene

Published in: Endocrine connections (2022)

Immunoassay measurement of estradiol in transgender women may lead to falsely decreased concentrations that have the potential to affect management. A multidisciplinary health care approach is needed to ensure if appropriate analytical methods are available.

Keyphrases

estrogen receptor
healthcare
sensitive detection
polycystic ovary syndrome
label free
pregnancy outcomes
hiv testing
adipose tissue
mass spectrometry
breast cancer risk
climate change
hepatitis c virus
hiv infected